- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT07941375
Gamified Dual-Task Training for Balance and Exercise Enjoyment in Children With Spastic Cerebral Palsy
Effects of Low-Cost Gamified Motor-Cognitive Dual-Task Training on Balance and Exercise Enjoyment in Ambulatory Children and Adolescents With Spastic Cerebral Palsy Aged 11-17 Years: A Randomized Controlled Trial
This randomized controlled trial will investigate whether a low-cost gamified motor-cognitive dual-task training program improves balance and exercise enjoyment more than standard single-task balance training in ambulatory children and adolescents with spastic cerebral palsy aged 11-17 years. Sixty participants attending a special education and rehabilitation center will be randomly assigned to one of two groups. Both groups will continue their routine physiotherapy and receive 30-minute balance training sessions twice a week for 12 weeks. The control group will perform standard single-task balance exercises, while the intervention group will perform the same motor tasks combined with simultaneous cognitive tasks (e.g., counting backwards, naming categories, selecting colored targets) delivered in a game format with low-cost equipment (balls, colored tape, cones, steps). Balance (Pediatric Balance Scale), timed up and go performance under single- and dual-task conditions, gross motor function, walking capacity and exercise enjoyment will be assessed at baseline, after 12 weeks and at a 4-week follow-up by an assessor blinded to group allocation.
Visão geral do estudo
Status
Condições
Descrição detalhada
Background: Balance impairment is a core limitation in children with spastic cerebral palsy (CP). Dual-task training, which combines motor and cognitive tasks, has been shown in meta-analyses to improve balance more than single-task training; however, most programs rely on computer- or virtual-reality-based systems, and the effect of low-cost, device-free gamified dual-task programs on both balance and exercise enjoyment has not been investigated.
Design: Assessor-blinded, two-arm, parallel-group, 1:1 randomized controlled trial with a 12-week intervention and a 4-week follow-up. Participants will be stratified by Gross Motor Function Classification System (GMFCS) level (I-II vs III) and randomized using a computer-generated block randomization list with sequentially numbered, opaque, sealed envelopes prepared by an investigator not involved in treatment or assessment.
Interventions: Both groups will continue routine physiotherapy (2 sessions/week, 40 minutes) at the center and will additionally receive balance training 2 days/week, 30 minutes/session, for 12 weeks. The control group will receive standard single-task balance training (tandem and single-leg stance, weight shifting, line walking, step up/down, standing on narrow and compliant surfaces) with verbal instructions and without concurrent cognitive tasks. The intervention group will perform the same motor tasks combined with simultaneous cognitive tasks (serial subtraction, category naming, letter-number sequencing, stepping or throwing to colored targets according to verbal cues, simple arithmetic) delivered in a game format (colored targets, ball games, points/stars per session, weekly level progression, personal best records). Progression will be applied every 2 weeks along motor (support surface, speed, vision) and, in the intervention group, cognitive (task difficulty) dimensions. All sessions will be delivered by the same physiotherapist according to a written protocol and documented on a session log. No digital devices will be used.
Outcomes: Assessments will be performed at baseline (T0), at the end of the 12-week intervention (T1) and 4 weeks after the end of the intervention (T2) by a second physiotherapist blinded to group allocation. The primary outcome is the Pediatric Balance Scale. Secondary outcomes are the Timed Up and Go test under single- and dual-task (serial subtraction) conditions and the derived dual-task cost, the Gross Motor Function Measure-88 dimensions D and E, the 1-Minute Walk Test and the Physical Activity Enjoyment Scale (PACES-8, Turkish version). All scales have validated Turkish versions.
Sample size: Based on the minimal clinically important difference of the Pediatric Balance Scale in children with CP (approximately 5.8 points, SD approximately 7; effect size d = 0.80), alpha = 0.05 and power = 80%, 26 participants per group are required; allowing for 15% attrition, 30 participants per group (total 60) will be recruited.
Analysis: Intention-to-treat analysis with multiple imputation for missing data. The primary outcome at 12 weeks will be compared between groups by analysis of covariance adjusted for baseline score and GMFCS stratum. Changes across the three time points will be analyzed with linear mixed-effects models including group, time and group × time interaction. Effect sizes (partial eta squared, Cohen d) with 95% confidence intervals will be reported. Significance will be set at p < 0.05.
Tipo de estudo
Inscrição (Estimado)
Estágio
- Não aplicável
Contactos e Locais
Contato de estudo
- Nome: Ömer Şevgin
- Número de telefone: +905069787535
- E-mail: omer.sevgin@uskudar.edu.tr
Locais de estudo
-
-
Güngören
-
Istanbul, Güngören, Turquia (Türkiye)
- Bizim Çocuklarımız SPECIAL EDUCATION AND REHABILITATION CENTER
-
Contato:
- Amin Danesfhar
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Descrição
Inclusion Criteria:
- Age 11-17 years
- Diagnosis of spastic (unilateral or bilateral) cerebral palsy confirmed by a pediatric neurologist
- Gross Motor Function Classification System (GMFCS) level I, II or III
- Ability to walk independently for at least 10 meters with or without an assistive device
- Ability to understand and follow two-step verbal commands
- Receiving physiotherapy at the study center twice a week for at least 3 months
- Written informed consent from the parent/legal guardian and written assent from the participant
Exclusion Criteria:
- Botulinum toxin injection to the lower extremities within the last 6 months
- Orthopedic surgery within the last 6 months
- Uncontrolled epilepsy
- Uncorrected visual or hearing impairment
- Severe intellectual disability preventing performance of the cognitive tasks (counting, color discrimination)
- Participation in another structured balance or exercise program during the study period
- Uncontrolled cardiac or respiratory disease precluding exercise
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Tratamento
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Solteiro
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Experimental: Gamified motor-cognitive dual-task training
Routine physiotherapy (2 sessions/week, 40 min) plus gamified motor-cognitive dual-task balance training, 2 days/week, 30 min/session, for 12 weeks. Motor balance tasks are combined with simultaneous cognitive tasks and delivered in a game format using low-cost equipment. |
Balance exercises (tandem and single-leg stance, weight shifting, line walking, step up/down, standing on narrow/compliant surfaces) performed simultaneously with cognitive tasks (serial subtraction by 3s progressing to 7s, category naming, letter-number sequencing, stepping/throwing to colored targets on verbal cue, simple arithmetic). Delivered in a game format: colored floor and wall targets, ball catching/throwing and target games, points/stars per session, weekly level progression and personal best records. Progression every 2 weeks on motor (support surface, speed, vision) and cognitive (task difficulty) dimensions. Equipment: balls, colored tape, cones, steps; no digital devices. 2 days/week × 30 min × 12 weeks, delivered one-to-one by a physiotherapist. The same balance exercises (tandem and single-leg stance, weight shifting, line walking, step up/down, standing on narrow/compliant surfaces) performed with verbal instructions only, without concurrent cognitive tasks or game elements. Progression every 2 weeks on support surface, speed and vision. 2 days/week × 30 min × 12 weeks, delivered one-to-one by a physiotherapist. |
|
Comparador Ativo: Standard single-task balance training
Routine physiotherapy (2 sessions/week, 40 min) plus standard single-task balance training, 2 days/week, 30 min/session, for 12 weeks. Same motor tasks as the experimental arm, delivered with verbal instructions and without concurrent cognitive tasks or game elements. |
The same balance exercises (tandem and single-leg stance, weight shifting, line walking, step up/down, standing on narrow/compliant surfaces) performed with verbal instructions only, without concurrent cognitive tasks or game elements. Progression every 2 weeks on support surface, speed and vision. 2 days/week × 30 min × 12 weeks, delivered one-to-one by a physiotherapist. |
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Pediatric Balance Scale (PBS) score at 12 weeks
Prazo: Week 12 (end of intervention)
|
The PBS is a 14-item functional balance scale for children, each item scored 0-4; total score 0-56, higher scores indicate better balance. Turkish version validated in children with cerebral palsy. |
Week 12 (end of intervention)
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Change in Pediatric Balance Scale (PBS) score
Prazo: Baseline, Week 12, Week 16 (4-week follow-up)
|
Same scale as the primary outcome; change from baseline. |
Baseline, Week 12, Week 16 (4-week follow-up)
|
|
Timed Up and Go (TUG) test - single task
Prazo: Baseline, Week 12, Week 16
|
Time (seconds) to stand from a chair, walk 3 m, turn, return and sit; mean of three trials. Lower values indicate better functional mobility. |
Baseline, Week 12, Week 16
|
|
Gross Motor Function Measure-88 (GMFM-88), Dimension D (standing)
Prazo: Baseline, Week 12, Week 16
|
13 items scored 0-3; dimension percentage score 0-100, higher scores indicate better gross motor function. Turkish version validated. |
Baseline, Week 12, Week 16
|
|
1-Minute Walk Test (1MWT)
Prazo: Baseline, Week 12, Week 16
|
Distance (meters) walked in 1 minute at a comfortable pace; higher values indicate better walking capacity. |
Baseline, Week 12, Week 16
|
|
Physical Activity Enjoyment Scale (PACES-8, Turkish version)
Prazo: Baseline, Week 12, Week 16
|
8 items rated on a 7-point Likert scale; total score 8-56, higher scores indicate greater enjoyment of physical activity. |
Baseline, Week 12, Week 16
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Cadeira de estudo: Amin Danesfhar, Üsküdar University
Publicações e links úteis
Publicações Gerais
- Erden A, Acar Arslan E, Dundar B, Topbas M, Cavlak U. Reliability and validity of Turkish version of pediatric balance scale. Acta Neurol Belg. 2021 Jun;121(3):669-675. doi: 10.1007/s13760-020-01302-9. Epub 2020 Feb 19.
- Szturm T, Parmar ST, Mehta K, Shetty DR, Kanitkar A, Eskicioglu R, Gaonkar N. Game-Based Dual-Task Exercise Program for Children with Cerebral Palsy: Blending Balance, Visuomotor and Cognitive Training: Feasibility Randomized Control Trial. Sensors (Basel). 2022 Jan 19;22(3):761. doi: 10.3390/s22030761.
- Cortes-Perez I, Castillo-Pintor MLA, Barrionuevo-Berzosa R, Pinar-Lara M, Obrero-Gaitan E, Garcia-Lopez H. Dual-Task Training Interventions for Cerebral Palsy: A Systematic Review and Meta-Analysis of Effects on Postural Balance and Walking Speed. Medicina (Kaunas). 2025 Aug 5;61(8):1415. doi: 10.3390/medicina61081415.
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Estimado)
Conclusão Primária (Estimado)
Conclusão do estudo (Estimado)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
- Manifestações Neurológicas
- Doenças musculoesqueléticas
- Doenças Cerebrais
- Doenças do Sistema Nervoso Central
- Doenças do Sistema Nervoso
- Doenças Musculares
- Hipertonia muscular
- Manifestações Neuromusculares
- Dano Cerebral, Crônico
- Condições Patológicas, Sinais e Sintomas
- Sinais e sintomas
- Espasticidade muscular
- Paralisia cerebral
Outros números de identificação do estudo
- Uskudar30
- Üsküdar University (Outro identificador: Non-Interventional Research Ethics Committee)
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Descrição do plano IPD
De-identified individual participant data may be made available from the principal investigator upon reasonable request after publication of the main results.
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .